Maestro MEA platform powers first stem cell cardiac safety assay in FDA ISTAND program
This assay uses hiPSC‑derived cardiomyocytes with Maestro MEA technology to measure electrophysiology across a functional cardiac syncytium
This assay uses hiPSC‑derived cardiomyocytes with Maestro MEA technology to measure electrophysiology across a functional cardiac syncytium
Bioxytran’s drug candidate, PHM23, utilizes a novel mechanism of action that targets galectin proteins critical to viral replication
A breakthrough approach that overcomes scale-up and consistency challenges in microsphere production
In this SelectScience interview, discover why AI in clinical data management must prioritize transparency, traceability, and reproducibility to earn trust in regulated environments
Strategic data collaboration will allow pharmaceutical and biotech companies to connect real-world data with clinical research
TarSeer™ BRETSA™ Target Engagement System enables studies for difficult proteins early in drug discovery
VectorBuilder’s Alan Griffith explains the value of MoA-reflective potency assays for gene therapy development and the benefits of working with assay specialists like Svar Life Science
Tahoe Therapeutics aims to use the speed and accuracy of these automated systems to generate a dataset fifty times larger than its already record-breaking Tahoe 100 million single-cell atlas
A computer simulation technique known as molecular dynamics will be used to study how G-protein-coupled receptors interact with the intracellular effector inside the cell
EpiFinder Analysis Service establishes a new standard for accessible, end-to-end epigenomic analysis, enabling researchers to move confidently from study concept to biological insights
How two CROs are uniting ligand-binding assays and LC-MS expertise to tackle the complexity of modern biologics
Newly patented MICRO‑TAG platform brings real‑time, in‑cell target engagement to the forefront of drug discovery
Equipping labs with a frictionless R&D environment where execution, analytics, and learning are natively connected
How Emulate's 96-chip AVA™ Emulation System is helping pharmaceutical companies transition to human-relevant testing under new FDA and UK regulatory guidelines
Recognizing the most impactful technologies and content across the drug discovery and development pipeline, as voted for by scientists worldwide
The DynamicOrgan O₂ Sensor Kit enables continuous, non-invasive monitoring of oxygen levels for human-relevant disease and drug models
The Invitrogen™ TaqMan™ Cells-to-CT™ HepatoExpress Kit lets researchers measure gene activity in liver cells without doing RNA purification, so they can go from sample to results in about 75 minutes, with only 10 minutes of hands-on work
See how Nautilus Biotechnology’s Iterative Mapping platform combines ultra-sensitive protein analysis and AI-driven insights for deeper biological understanding
Every biomarker in Aliri’s study-ready panels is carefully selected and rigorously verified for its intended biological context
Expansion of iXCells’ iPSCore platform with integration of 3D human organoid expertise will enable evaluation of drug toxicity and tissue-specific responses
Guest editorial from Dr. Matt Westfall, Senior Director of Biochemical Pharmacology and Proteomics at Inotiv
testo Saveris 1 provides automated and efficient support in complying with regulatory requirements
Offers reliable, compliant, and accessible solutions to advance scientific discovery and product development